Patents by Inventor David Simpkin

David Simpkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11954934
    Abstract: Systems for item validation and image evaluation are provided. In some examples, a system may receive an instrument and associated data. The instrument may be received and at least one of a bill pay profile and a user profile may be retrieved. The bill pay profile and user profile may each include a plurality of previously processed instruments that have been determined to be valid and/or authentic. The instrument may be compared to the plurality of previously processed instruments to determine whether one or more elements of the instrument being evaluated match one or more corresponding elements of the plurality of previously processed instruments. Matching or non-matching elements may be identified. In some examples, one or more user interfaces may be generated displaying the instruments and including any highlighting or enhancements identifying matching or non-matching elements.
    Type: Grant
    Filed: September 14, 2022
    Date of Patent: April 9, 2024
    Assignee: Bank of America Corporation
    Inventors: Jasher David Fowles, Kerry Kurt Simpkins, John B. Hall, Murali Santhanam, Jeanne M. Moulton, Michael J. Pepe
  • Patent number: 8685654
    Abstract: Influenza hemagglutinin (HA) binds to aluminum salt adjuvants and cannot easily be directly assayed directly a single radial immunodiffusion (SRID) test. The invention modifies the SRID protocol for an adsorbed antigen by including a step in which antigen is desorbed prior to diffusion.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: April 1, 2014
    Assignee: Novartis AG
    Inventors: Philip J. Sizer, Jane King-Haughey, David Simpkin, Roger Williams
  • Publication number: 20110045457
    Abstract: Influenza hemagglutinin (HA) binds to aluminium salt adjuvants and cannot easily be directly assayed directly a single radial immunodiffusion (SRID) test. The invention modifies the SRID protocol for an adsorbed antigen by including a step in which antigen is desorbed prior to diffusion.
    Type: Application
    Filed: December 24, 2008
    Publication date: February 24, 2011
    Applicant: NOVARTIS AG
    Inventors: Philip J. Sizer, Jane King-Haughey, David Simpkin, Roger Williams